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Abstract
Acinetobacter baumannii is an important nosocomial pathogen that causes a high morbidity and mortality rate in infected
patients, but pathogenic mechanisms of this microorganism regarding the secretion and delivery of virulence factors to
host cells have not been characterized. Gram-negative bacteria naturally secrete outer membrane vesicles (OMVs) that play
a role in the delivery of virulence factors to host cells. A. baumannii has been shown to secrete OMVs when cultured in vitro,
but the role of OMVs in A. baumannii pathogenesis is not well elucidated. In the present study, we evaluated the secretion
and delivery of virulence factors of A. baumannii to host cells via the OMVs and assessed the cytotoxic activity of outer
membrane protein A (AbOmpA) packaged in the OMVs. A. baumannii ATCC 19606
T secreted OMVs during in vivo infection
as well as in vitro cultures. Potential virulence factors, including AbOmpA and tissue-degrading enzymes, were associated
with A. baumannii OMVs. A. baumannii OMVs interacted with lipid rafts in the plasma membranes and then delivered
virulence factors to host cells. The OMVs from A. baumannii ATCC 19606
T induced apoptosis of host cells, whereas this effect
was not detected in the OMVs from the DompA mutant, thereby reflecting AbOmpA-dependent host cell death. The N-
terminal region of AbOmpA22-170 was responsible for host cell death. In conclusion, the OMV-mediated delivery of virulence
factors to host cells may well contribute to pathogenesis during A. baumannii infection.
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Introduction
Acinetobacter baumannii is an important nosocomial pathogen that
causes a variety of human infections, particularly in severely ill
patients [1,2]. Multi-drug resistance or pan-drug resistance to
clinically available antimicrobial agents in this organism induces
serious therapeutic issues [3,4]. A. baumannii is generally regarded
as a low virulent pathogen [2,3], but the full genome sequencing
shows that this organism harbors a remarkable number of putative
virulence-associated genes and elements homologous to the
Legionella/Coxiella type IV secretion apparatus [5]. Several
virulence determinants, such as biofilm formation [6,7], adherence
and ability to invade host cells [8,9], as well as iron acquisition [10]
and host cell death [11], have been assessed in previous studies. In
prior studies, we determined that the bacterial molecules secreted
from A. baumannii were directly responsible for host cell death [12].
Among the variety of bacterial molecules, outer membrane protein
Ao fA. baumannii (AbOmpA) was identified as a potential virulence
factor to induce host cell death via both mitochondrial and nuclear
targeting [11,13]. However, the secretion and delivery of
AbOmpA to host cells remain to be thoroughly elucidated.
A wide variety of Gram-negative bacterial species have been
demonstrated to secrete outer membrane vesicles (OMVs) during
bacterial growth [14]. OMVs are spherical nanovesicles with an
average diameter of 20–200 nm and are composed of lipopoly-
saccharides (LPS), proteins, lipids, and DNA or RNA [15–18].
Moreover, OMVs produced by pathogenic Gram-negative
bacteria harbor toxins and specific virulence factors, including
the heat-labile toxins of enterotoxigenic Escherichia coli (ETEC)
[19,20], the Shiga toxin of E. coli O157:H7 [21], the cytolethal
distending toxin of Campylobacter jejuni [22], and the Cif protein of
Pseudomonas aeruginosa [23]. Upon the delivery of virulence factors
to host cells, OMVs perform an important function in bacterial
pathogenesis without the direct interaction between the pathogens
and the host cells.
We demonstrated recently that a clinical isolate of A. baumannii
DU202 secreted OMVs into the extracellular milieu during in vitro
growth; additionally, several putative virulence factors were
identified in the OMVs of A. baumannii DU202 [24], thereby
suggesting that A. baumannii OMVs may serve to deliver virulence
factors to host cells. In this study, we evaluated the direct effects of
A. baumannii OMVs on host cells, particularly, the secretion of
OMVs from A. baumannii during in vivo infection, the delivery of
virulence factors to host cells via OMVs and subsequent
cytotoxicity. Here we report that A. baumannii OMVs represent a
vehicle for the delivery of bacterial molecules to host cells and also
that a potential virulence factor AbOmpA enriched in the OMVs
contributes directly to host cell death.
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Secretion of OMVs from A. baumannii
We first analyzed the secretion of OMVs from A. baumannii
ATCC 19606
T during in vitro culture. Bacteria were cultured in
Luria-Bertani (LB) broth and OMVs were collected from the
culture supernatants. Transmission electron microscopy (TEM)
demonstrated that A. baumannii secreted spherical vesicles into the
extracellular milieu (Fig. 1A). Next, in order to evaluate the
secretion of OMVs from A. baumannii during in vivo infection,
immunocompromised mice were infected intratracheally with
1610
7 CFU of A. baumannii ATCC 19606
T and sacrificed 48 h
after bacterial injection. The histological examination demonstrated
hemorrhage,necrosis, and infiltrationofpolymorphonuclear cellsin
both lung tissues (data not shown). TEM analysis revealed the
budding of spherical nanovesicles from bacterial surfaces in the
infected lung tissues (Fig. 1B and 1C). These results indicate that A.
baumannii secretes OMVs during in vivo infection and the secreted
OMVs are likely to interact with host cells without any direct
contact between the pathogens and the host cells.
Virulence factors packaged in A. baumannii OMVs
Proteomic analysis was conducted to identify proteins packaged
in the OMVs from A. baumannii ATCC 19606
T. Ultimately, a total
of 113 proteins were identified (Table S1). A putative outer
membrane protein (A1S_0884) with a molecular mass of 22.5 kDa
was detected in the highest abundance, followed by AbOmpA
(A1S_2840) with a molecular mass of 38.4 kDa. The cellular
localization of proteins identified in the A. baumannii OMVs was
predicted to occur in the extracellular space (n=1), outer
membrane (n=26), periplasmic space (n=8), inner membrane
(n=4), cytosol (n=17), and unknown sites (n=57). Virulence-
associated proteins, including AbOmpA, CsuA/B (A1S_2218),
CsuC (A1S_2215), CsuD (A1S_2214), putative hemolysin
(A1S_1321), putative serine protease (A1S_2525), Cu/Zn super-
oxide dismutase (A1S_3143), fimbrial protein (A1S_1510), bacter-
ioferritin (A1S_3175), RND superfamily transporter (A1S_0116),
putative RND type efflux pump (A1S_0009), and putative
protease (A1S_2470), were found in the OMVs of A. baumannii
ATCC 19606
T.
In order to determine whether AmpC b-lactamase (A1S_2367)
identified in the A. baumannii OMVs were biologically active, the
prepared OMVs were incubated with the b-lactamase substrate,
nitrocefin. This showed that the b-lactamases associated with A.
baumannii OMVs degraded nitrocefin, as demonstrated by the
colorization of nitrocefin (Fig. 2A). Moreover, the results of Western
blot analysis demonstrated that the full length of AbOmpA with a
molecular mass of 38.4 kDa was detected in the A. baumannii OMVs
(Fig. 2B). These results indicate that A. baumannii OMVs harbor
biologically active virulence factors and enzymes, which can
perform diverse biologic processes in host cells.
Delivery of virulence factors to host cells via OMVs
Based on the results of proteome analysis showing that A.
baumannii packaged multiple virulence factors into OMVs, we
assessed the delivery of virulence factors to host cells via the
OMVs. Three human cell lines, HeLa cell, HEp-2 cells, and U937
cells, were treated with OMVs acquired from A. baumannii ATCC
19606
T for 24 h and the cellular distribution of AbOmpA, a
documented OMV protein, was analyzed via confocal microscopy.
The cells were treated with 49,6-diamidino-2-phenyllindole
dihydrochloride (DAPI) for nuclear staining and anti-AbOmpA
polyclonal antibody, followed by Alexa FluorH 488 or 568 for
AbOmpA. Green or red fluorescence was noted principally in the
cytosolic compartments of the cells, but some fluorescence was
noted within the nuclei (Fig. 3A). Western blot analysis showed
that the full length of AbOmpA appeared within the cells at
30 min and remained there for more than 12 h (Fig. 3B).
The OMVs from E. coli and P. aeruginosa bind to host cells via
lipid rafts, after which bacterial effector molecules are translocated
into the cytosolic compartment [20,23]. In an effort to determine
whether or not A. baumannii OMVs delivered virulence factors to
host cells via lipid rafts, HeLa cells were pretreated with a
cholesterol-destroying agent, methyl-b-cyclodextrin (MbCD), and
subsequently treated with OMVs for 4 h. We used HeLa cells to
exclude the involvement of caveolins in the interactions of host
cells with OMVs because these cells did not harbor caveolins in
the cytoplasmic membrane [25]. AbOmpA was detected in the
cytosol of HeLa cells treated with A. baumannii OMVs (Fig. 4A),
whereas pretreatment of MbCD completely inhibited the cellular
localization of AbOmpA in HeLa cells treated with OMVs
(Fig. 4B), thereby indicating that a cholesterol-rich membrane
microdomain is required for the delivery of virulence factors
packaged in the A. baumannii OMVs to host cells.
Figure 1. Secretion of OMVs from A. baumannii during in vitro culture and in vivo infection. (A) Transmission electron micrograph of OMVs
prepared from A. baumannii ATCC 19606
T cultured in LB broth for 24 h. (B and C) Secretion of OMVs from A. baumannii ATCC 19606
T in a murine
pneumonia model. Mice were infected with 1610
7 CFU of bacteria intratracheally and sacrificed 48 h after bacterial injection. Arrows indicate the
OMVs secreted from A. baumannii.
doi:10.1371/journal.pone.0017027.g001
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PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17027Figure 2. A. baumannii OMVs contain biologically active proteins. (A) A. baumannii OMVs were incubated with 100 mM nitrocefin in PBS at
30uC for 30 min. Hydrolysis of nitrocefin was monitored at 480 nm using a UV spectrophotometer. Inlet figure: left, brown colorization of nitrocefin in
A. baumannii OMVs; right, negative control of nitrocefin in PBS. (B) SDS-PAGE of proteins packaged in the OMVs from A. baumannii ATCC 19606
T
(lanes 1 and 2) and its Western blot analysis (lanes 3 and 4). The samples were immunoblotted with a rabbit anti-AbOmpA immune serum. Lanes 1
and 3, molecular weight maker; 2 and 4, OMV fraction. Arrows indicate AbOmpA.
doi:10.1371/journal.pone.0017027.g002
Figure 3. A. baumannii OMVs deliver virulence factor AbOmpA into host cells. (A) HeLa and HEp-2 cells were treated with A. baumannii
OMVs (5 mg/ml of protein concentrations) for 12 h. The cells were fixed, permeabilized, and stained with anti-rabbit AbOmpA antibody, followed by
Alexa FluorH 568-conjugated rabbit IgG (red). DAPI was used to stain the nuclei (blue). Magnification:6400. The U937 cells were treated with 5 mg/ml
of A. baumannii OMVs for 4 h and then stained with anti-rabbit AbOmpA antibody, followed by Alexa FluorH 488-conjugated rabbit IgG (green).
Magnification: 61,260. (B) Western blot analysis of cell lysates. The differentiated U937 cells were treated with A. baumannii OMVs (20 mg/ml of
protein concentrations) for the indicated times. Cell lysates were separated on 12% SDS-PAGE, transferred to membranes, and immunoblotted with a
rabbit anti-AbOmpA immune serum and b-actin antibody.
doi:10.1371/journal.pone.0017027.g003
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In order to determine whether A. baumannii OMVs induced host
cell damage, macrophages were treated with various concentra-
tions of OMVs for 24 h and then stained with Annexin V and
propidium iodide (PI). The U937 cells were used in this study
because macrophages had low threshold concentrations of
AbOmpA for cell death as compared with epithelial cells (HEp-
2 cells) and fibroblast cells (Cos-7 cells) [13]. Flow cytometric
analysis demonstrated no cell death at #20 mg/ml (protein
concentrations) of OMVs, but 50 and 100 mg/ml of OMVs did
induce host cell death (Fig. 5, middle panel). Based on previous
studies demonstrating that AbOmpA directly induced apoptotic
cell death, OMVs were prepared from the DompA mutant and
their ability to induce cytotoxicity was compared to that of the
OMVs from wild-type A. baumannii. The OMVs from the DompA
mutant did not induce cell death evenly at a concentration of
100 mg/ml (Fig. 5, lower panel). These results suggest that
AbOmpA associated with A. baumannii OMVs is directly
responsible for host cell death.
In order to determine which AbOmpA domains were directly
responsible for host cell death, three recombinant proteins,
including rAbOmpA22-170, rAbOmpA221-339, and rAbOmpA1-
356, were generated and then micelles harboring each rAbOmpA
fragment were constructed to insert rAbOmpA proteins into the
membrane or lumen according to their hydrophobicity. These
micelles were treated to HeLa cells for 24 h, after which the
cellular distribution of rAbOmpA was assessed. Three different
rAbOmpA proteins were internalized by host cells (Fig. 6A). Next,
the cytotoxicity of different rAbOmpA proteins was assessed in the
macrophages. Micelles composed of rAbOmpA22-170 and rA-
bOmpA1-356 induced cell death at a concentration of $5 mg/ml,
whereas rAbOmpA221-339 did not induce cell death at a
concentration of #100 mg/ml (Fig. 6B). These results indicate
that the N-terminal resides of AbOmpA are responsible for host
cell death.
Discussion
In our previous studies to identify the virulence factors of A.
baumannii, we demonstrated that AbOmpA induced host cell death
via both mitochondrial and nuclear targeting [11,13]. However,
the secretion of AbOmpA from bacteria and its delivery to host
cells have yet to be characterized. AbOmpA is a porin that allows
for the passing of small solutes in the outer membrane and is one
of the most abundant proteins in culture supernatants [11,24].
Thus, we hypothesized that A. baumannii packaged AbOmpA into
OMVs and that the OMV-mediated delivery of AbOmpA to host
cells induced cytotoxicity. In this study, we identified A. baumannii
OMVs as an important vehicle for the delivery of AbOmpA to
host cells, after which AbOmpA packaged in OMVs induced
cytotoxicity. These results help to establish that the previously
uncharacterized secretion and delivery pathways of AbOmpA
induce host cell death.
Proteome analysis of OMVs from A. baumannii ATCC 19606
T
and a clinical isolate of A. baumannii DU202 identified more than
110 proteins derived from the outer membrane, periplasmic space,
inner membrane, cytosol, and unknown sites [24]. Twenty-one
inner membrane and cytosolic proteins were identified in the
OMVs, although OMVs were not likely to contain inner
membrane and cytosolic components during the vesicle biogenesis
[14,15]. However, several proteomic studies demonstrated that
some inner membrane and cytosolic proteins were also present in
the OMV preparations [17,18,26–28]. A putative outer mem-
brane protein (A1S_0884) with a molecular mass of 22.5 kDa was
the most abundant in the proteomic analysis of OMVs (Table S1),
but 1-dimentional SDS-PAGE showed the most dense band in the
Figure 4. A. baumannii OMVs interact with plasma membrane of host cells through a cholesterol-rich membrane microdomain. (A)
HeLa cells were treated with OMVs (5 mg/ml of protein concentrations) for 4 h. (B) HeLa cells were preterated with 10 mM MbCD for 45 min and then
treated with OMVs for 4 h. The cells were fixed, permeabilized, and stained with anti-rabbit AbOmpA antibody, followed by Alexa FluorH 488-
conjugated rabbit IgG (green). DAPI was used to stain the nuclei (blue). Magnification: 6630.
doi:10.1371/journal.pone.0017027.g004
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the presence of several proteins with a similar molecular mass,
such as putative competence protein (ComL) (40.6 kDa), hypo-
thetical protein A1S_1691 (39.2 kDa), AbOmpA (38.4 kDa), b-
lactamase (37.3 kDa), hypothetical protein A1S_0505 (36.5 kDa),
and putative RND type efflux pump (35.6 kDa). The protein
composition of OMVs varied between A. baumannii ATCC 19606
T
and a clinical isolate DU202. Virulence-associated proteins,
including AbOmpA, putative RND efflux pump (A1S_0009),
bacterioferritin (A1S_3175), and several putative outer membrane
proteins, were identified commonly in both A. baumannii strains,
whereas CsuA/B, CsuC, CsuD, fimbrial protein, and putative
hemolysin were identified only in the OMVs from A. baumannii
ATCC 19606
T (Table S1). The protein compositions of the
OMVs prepared from a clinical P. aeruginosa isolate and from
laboratory strain PAO1 differed significantly [29,30], thus eliciting
a different pro-inflammatory cytokine response in macrophages
[31]. Accordingly, the strain-specific protein compositions or
virulence factor profiles in A. baumannii OMVs may result in
differences in the virulence of A. baumannii strains.
The OMV content is delivered to host cells via either receptor-
mediated endocytic pathway or the fusion with host cell plasma
membranes [32,33]. The results of this study demonstrated that a
cholesterol-rich membrane microdomain was required for the
delivery of AbOmpA packaged in A. baumannii OMVs to the
cytosol of host cells, thus reflecting the lipid raft-dependent
endocytosis of OMVs. Toxins and other vesicular membrane
components of OMVs were shown to bind specifically to the
receptors within lipid rafts [20,31]. The heat-labile toxins in
ETEC OMVs were bound to monosialoganglioside (GM1) [20].
Ellis et al. [31] reported that vesicular LPS and proteins were
responsible for the binding of P. aeruginosa OMVs to macrophage
surfaces and cellular internalization, respectively. Since AbOmpA
played a pivotal role in adherence to and invasion of A. baumannii
in epithelial cells [9], we attempted to determine whether
AbOmpA played a role in the interaction of A. baumannii OMV
with host cells. The DompA mutant of A. baumannii ATCC 19606
T
did not express AbOmpA in the outer membrane [11], but the
results of proteomic analysis demonstrated the existence of a
truncated AbOmpA in the OMVs from the DompA mutant (data
not shown), thereby suggesting that a truncated AbOmpA may be
located in the lumen of OMVs. When HeLa cells were treated
with OMVs from the DompA mutant, a truncated AbOmpA was
detected in the cytosol of host cells. These results indicate that the
Figure 5. Flow cytometric analysis of cell death induced by the OMVs from A. baumannii ATCC 19606
T and the DompA mutant. The
differentiated U937 cells were treated with various concentrations (0, 10, 20, 50, and 100 mg/ml) of OMVs and stained with Annexin V and PI. Upper
panel, control cells without OMVs for 24 h. Middle panel, the cells were treated with OMVs from A. baumannii ATCC 19606
T for 24 h. Lower panel, the
cells were treated with OMVs from the DompA mutant for 24 h. Representative data from three independent experiments are shown. In the graph,
cells in right upper and lower parts are apoptotic cells and cells in left upper part are necrotic cells.
doi:10.1371/journal.pone.0017027.g005
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independently of AbOmpA. Future studies will clearly be
necessary to identify the bacterial molecules associated with lipid
rafts. Moreover, the subsequent trafficking pathway of OMVs
following the entry should be clarified to elucidate A. baumannii
pathogenesis occurring by way of OMV-mediated cytotoxicity.
We previously demonstrated that AbOmpA purified from A.
baumannii ATCC 19606
T and rAbOmpA from E. coli caused death
in host cells [11,13], but the cytotoxic domains have yet to be
clearly identified. The results of the present study showed that
AbOmpA was the most potent cytotoxic molecule in the A.
baumannii OMVs and the N-terminal 170 residues of AbOmpA
were required for the induction of host cell death. A 50 mg/ml
(protein concentrations) of OMVs induced host cell death. Because
molecular percentage of AbOmpA was determined to be 9.08
based on the proteomic analysis of A. baumannii OMVs (Table S1),
an approximately 4.5 mg/ml of AbOmpA in the 50 mg/ml of
OMVs induced host cell death. Based on the prediction of the
tertiary structure of AbOmpA (http://www.pymol.org/), the N-
terminal 220 residues of AbOmpA traversed the outer membrane
with eight anti-parallel b-sheet segments and four external loops
exposed on the bacterial surface. Thus, the N-terminal residues of
AbOmpA, which may traverse the vesicular membrane and form
external loops in OMVs, induce cytotoxicity. However, the
translocation of AbOmpA located in the vesicular membrane to
the cytosolic compartment has yet to be characterized.
Figure 6. Host cell entry and cytotoxicity of rAbOmpA fragments. (A) HeLa cells were treated with different forms of micelles containing
rAbOmpA fragments for 24 h. The cells were fixed, permeabilized, and stained with anti-rabbit AbOmpA antibody, followed by Alexa FluorH 568-
conjugated rabbit IgG (red). DAPI was used to stain the nuclei (blue). The subcellular localization of AbOmpA was observed by confocal microscopy.
Magnification: 6400. (B) The differentiated U937 cells were treated with different forms of micelles containing rAbOmpA fragments for 24 h. Cell
viability was determined by a WST-1 assay. Untreated control cells (X), rAbOmpA22-170 (N), rAbOmpA1-356 (X), and rAbOmpA221-339 (&).
doi:10.1371/journal.pone.0017027.g006
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previously been determined in a variety of pathogenic Gram-
negative bacteria, including ETEC [20], uropathogenic E, coli
[34], Helicobacter pylori [35,36], Actinobacillus actinomycetemcomitans
[37], Vibrio cholerae [38], and P. aeruginosa [29]. In this study, we
demonstrate that OMVs are an important secretory vehicle for the
delivery of virulence factors to host cells in A. baumannii. The
OMV-mediated cytotoxicity occurring via AbOmpA is a crucial
regulator in the induction of host cell death. Further studies of the
virulence attributes of each virulence factor packaged in OMVs
are expected to provide insights into the association of A. baumannii
pathogenesis and alterations of host cell biology.
Materials and Methods
Bacterial strains and cell culture
A. baumannii ATCC 19606
T and isogenic DompA mutant (KS37)
were employed to prepare the OMVs [11]. E. coli BL21 (DE3) was
employed in the preparation of the rAbOmpA proteins. The
organisms were maintained on blood agar plates or MacConkey
agar plates, and cultivated in LB broth. HEp-2 cells from laryngeal
epithelial cells, HeLa cells from cervical carcinoma, and U937 cells
from monocytes were employed in this study. HEp-2 cells and
HeLa cells were grown in Dulbecco’s modified Eagle medium
(HyClone) supplemented with 10% fetal bovine serum (FBS,
HyClone), 2 mM L-glutamine, 1000 U/ml penicillin G, and
50 mg/ml streptomycin at 37uCi n5 %C O 2. U937 monocytes
were differentiated into macrophages for three or four days and
matured via the addition of 500 ng/ml of phorbol 12-myristate
13-acetate (Sigma-Aldrich). Macrophages were cultured in RPMI-
1640 (Gibco BRL) supplemented with 10% FBS and 2 mM L-
glutamine at 37uCi n5 %C O 2.
Purification of OMVs from bacterial culture supernatants
The OMVs from A. baumannii were prepared as previously
described [18,39]. In brief, bacteria were grown in 500 ml of LB
broth until the optical density at 600 nm (OD600) reached 1.0 at
37uC with shaking. Bacterial cells were removed via 15 min of
centrifugation at 6,000 x g at 4uC. The supernatants were filtered
through a 0.2 mm vacuum filter to remove residual cellular debris.
The samples were concentrated via ultrafiltration with a Quix-
Stand Benchtop System (GE Healthcare) using a 100 kDa hollow
fiber membrane (GE Healthcare), which could exclude molecules
with a molecular mass of 100 kDa in the samples. The OMVs
were collected via 3 h of ultracentrifugation at 150,000 x g at 4uC
and resuspended in phosphate-buffered saline (PBS). The protein
concentration was then determined using a modified BCA assay
(Thermo Scientific). The purified OMVs were checked for sterility
and stored at 280uC.
Production of rAbOmpA and micelle formation
The ompA gene was amplified from A. baumannii ATCC 19606
T
and cloned into the pET28a expression vector (Novagen) [13,40].
The recombinant proteins were overexpressed in E. coli BL21
(DE3) and loaded onto a HiTrap
TM FF column (Amersham
Biosciences) to elute His-tagged rAbOmpA. The rAbOmpA was
incubated with endotoxin removal resin (Sigma-Aldrich) for the
removal of LPS. The protein concentration was determined using
a modified BCA assay (Thermo Scientific). In order to construct
micelles, the purified rAbOmpA proteins, rAbOmpA1-356 and
rAbOmpA22-170, were incubated with 05% n-dodecyl-N,N-
dimethylamine-N-oxide in a buffer consisting of 20 mM Tris-
HCl (pH 8.0) and 100 mM NaCl. The hydrophilic rAbOmpA221-339
was mixed with 20 mM Tris-HCl (pH 6.8) and 100 mM NaCl.
Identification of proteins in A. baumannii OMVs
One-dimensional electrophoresis-liquid chromatography-tan-
dem mass spectrometry (1-DE-LC-MS/MS) was performed to
identify proteins packaged in the A. baumannii OMVs as described
previously [24,41]. Proteins were separated via 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and in-gel digested. The protein digests were resolved in 15 mlo f
0.02% formic acid in 0.5% acetic acid, and the samples were
concentrated on a MGU30-C18 trapping column (LC Packings)
and a nano-column (C18 reverse-phase column, Proxeon) at a flow
rate of 120 nl/min. The peptides were eluted by 0–65%
acetonitrile for 80 min. All MS and MS/MS spectra in the
LCQ-Deca ESI ion trap mass spectrometer were acquired in data-
dependent mode. The MS/MS spectra were searched using
MASCOT software (Matrix Science, Inc.) using the genome data
of A. baumannii ATCC 17978
T from NCBInr (http://www.ncbi.
nlm.nih.gov/) and the decoy sequence database. The exponen-
tially modified protein abundance index (emPAI) was generated
using MASCOT software [42].
Western blot analysis
Cells were treated with OMVs (20 mg/ml of protein concen-
trations) for the indicated time periods and then were lysed in lysis
buffer (10 mM Tris pH 7.4, 5 mM EDTA, 130 mM NaCl, 1%
Triton X-100, 10 mg/ml PMSF, 10 mg/ml aprotinin, 10 mg/ml
leupeptin, 5 mM phenanthroline, and 28 mM benzamidine-HCl)
for 30 min on ice. The lysates were clearly centrifugation and then
quantified using a modified BCA assay (Thermo Scientific). Each
sample was separated with 12% sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis, followed by electrotransfer onto the
nitrocellulose membranes (Hybond-ECL; Amersham Pharmacia
Biotech). The blots were blocked in 5% non-fat skim milk and
incubated with a rabbit anti-AbOmpA immune serum and b-actin
antibodies (Santa Cruz Biotechnology). The membranes were
incubated with a secondary antibody coupled to horseradish
peroxidase and developed using an enhanced chemiluminescence
system (ECL plus; Amersham Pharmacia Biotech).
Cell proliferation assay
The growth of cell treated with different rAbOmpA proteins
was measured with a Premix WST1 cell proliferation assay system
(TaKaRa Shuzo) [11]. The cells were seeded at a concentration of
2.0610
5/ml in a 96-well microplate. After treating with different
concentrations of micelles for 24 h, cell growth was measured at
450 nm 3 h after treatment with WST1.
Flow cytometric analysis
Cells were treated with OMVs for 24 h and stained with FITC-
conjugated Annexin V and PI (BD Pharmingen) according to the
manufacturer’s instructions. The 1610
6 cells were stained with
FITC-conjugated Annexin V in Annexin V binding buffer for
15 min. PI was added to determine alterations in cell membrane
integrity. The samples were immediately analyzed by the flow
cytometry and CellQuest Pro software (BD Biosciences). For each
sample, 5,000 or 10
4 cells were acquired for data analysis.
Confocal microscopy
The cultured cells were seeded at a density of 5610
4 on glass
coverslips the day before the assay. After treating the OMVs, the
cells were washed in PBS, fixed in 4% paraformaldehyde and
permeabilized for 10 min in PBS containing 0.25% Triton X-100.
The OMVs were labeled with a polyclonal anti-rabbit AbOmpA
antibody, followed by Alexa-488- or Alexa-568-conjugated goat
A. baumannii Outer Membrane Vesicles
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cells were stained with DAPI (Molecular Probes). HeLa cells were
treated with 10 mM MbCD (Sigma-Aldrich) to disrupt cholester-
ol-rich membrane domains for 45 min in serum-free medium at
37uCi naC O 2 incubator. After washing with PBS, cells were
treated with OMVs. The samples were observed with a Carl-Zeiss
confocal fluorescent microscope.
Determination of b-lactamase activity
The chromogenic cephalosporin nitrocefin (Oxoid, U. K) was
used to determine b-lactamase activity [43]. The assay was
performed at 30uC with 100 mM nitrocefin in PBS (pH 7.4).
Hydrolysis was monitored at 480 nm using a UV spectrophotom-
eter (Shimadzu, Japan).
TEM analysis
After the resuspension of OMV preparations in PBS, the
samples were applied to copper grids and stained with 2% uranyl
acetate. The lung tissues removed from the infected mice were
fixed with 2.5% glutaraldehyde and post-fixed in 1% osmium
tetroxide. The samples were subsequently dehydrated in a series of
ethanol concentrations and embedded in Epon. Thin sections
were cut with an ultramicrotome (RMC Boeckeler Instruments)
equipped with a diamond knife and stained with 3% uranyl
acetate and lead citrate. The samples were then visualized with a
TEM (Hitachi H-7500, Hitachi, Japan) operated at 120 kV.
Mouse pneumonia model
Eight-week-old female C57BL/6 mice were maintained under
specific pathogen free conditions. Immunocompromised mice
were infected with A. baumannii ATCC 19606
T [9]. Neutropenic
mice were induced via intraperitoneal injections of cyclophospha-
mide (150 mg/Kg) on days -4 and -3 before bacterial injection
[44]. The mice were anesthetized with pentobarbital and then
100 mlo f1 610
8 cfu/ml of bacteria were administrated intratra-
cheally. The control mice were injected with 100 ml of PBS
(pH 7.4). The mice were sacrificed two days after bacterial
challenge and the lungs were removed. All procedures involving
animals were approved by the Animal Care Committee of
Kyungpook National University (KNU2010-40).
Supporting Information
Table S1 Proteins identified in the OMV fraction of A.
baumannii ATCC 19606
T using 1-DE and LC-MS/MS
analysis.
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